Insulin degludec biosimilar (Zhuhai United)

德古胰岛素生物类似药（珠海联邦）

Report date: 2026/03/10 18:07:08

Base Information

Drug NameInsulin degludec biosimilar (Zhuhai United)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryMainland China
Original Approved Date2026/03/03
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZhuhai United Laboratories Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuhai United Laboratories Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A